SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-064674
Filing Date
2016-05-12
Accepted
2016-05-12 07:02:47
Documents
40
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 WINDTREE THERAPEUTICS, INC. 10-Q 3-31-2016 form10q.htm 10-Q 447737
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9525
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8537
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6464
  Complete submission text file 0001140361-16-064674.txt   2474475

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20160331.xml EX-101.INS 354501
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20160331.xsd EX-101.SCH 30614
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20160331_cal.xml EX-101.CAL 33046
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20160331_def.xml EX-101.DEF 111175
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20160331_lab.xml EX-101.LAB 358544
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20160331_pre.xml EX-101.PRE 201182
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 161641626
SIC: 2836 Biological Products, (No Diagnostic Substances)